European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 4 , Pages 417-422 , April 2006

Temporary Access and Central Venous Catheters

  • A. Frankel

      Affiliations

    • Corresponding Author InformationCorresponding author. Dr A. Frankel, Consultant Nephrologist, Renal Business Office, West London Renal and Transplant Centre, Hammersmith Hospital, Ducane Road, London W12 OHS, UK.

,Accepted 5 October 2005.

References 

  1. Erben J, Kvasnicka J, Bastecky J, Vortel V. Experience with routine use of subclavian vein cannulation in Haemodialysis. Proc Eur Dial Transplant Assoc. 1969;6:59–64
  2. Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med. 1996;24:2053–2058
  3. Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy B, Barre E, et al. Complications of femoral and subclavian venous catheterisation in critically ill patients: a randomised controlled trial. JAMA. 2001;286:700–707
  4. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteraemia from temporary haemodialysis catheters by sit of insertion and duration of use. Kidney Int. 2000;58:2543–2545
  5. Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant. 1991;6:722–724
  6. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron. 1990;54:154–161
  7. Tokars JI, Miller ER, Stein G. New national surveillance system for haemodialysis associated infections: Initial results. AJIC. 2002;30:288–295
  8. Duncan ND, Singh S, Cairns TD, Clark M, El-Tayar A, Griffith M, et al. Tesio–Caths provide effective and safe long term vascular access. Nephrol Dial Transplant. 2004;19:2816–2822
  9. Guidelines for preventing infections associated with the insertion and maintenance of central venous catheters. J Hosp Infect 2001;47(Suppl):S47–S67.
  10. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of haemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int. 1991;40:934–938
  11. Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol. 1996;7:2403–2408
  12. Wayne Johnson D, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. Randomised controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant. 2002;17:1802–1807
  13. Chatzinikolaou I, Finkel K, Hanna H, Boktour M, Foringer J, Ho T, et al. Antibiotic-coated haemodialysis catheters for the prevention of vascular catheter-related infections: a prospective randomised study. AJM. 2003;115:352–357
  14. Priestman WS, Taal MW, Fluck RJ, McIntyre CW. Haemodialysis catheter/dysfunction is reduced by catheter restricted filling with gentamicin and heparin. Renal Assoc Annu Congress. 2005;P91
  15. Michiel GH, van Agteren B, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine—containing lock solution. Nephrol Dial Transplant. 2004;19:1546–1551

PII: S1078-5884(05)00600-3

doi: 10.1016/j.ejvs.2005.10.003

European Journal of Vascular & Endovascular Surgery
Volume 31, Issue 4 , Pages 417-422 , April 2006

Article Tools

* Image Usage & Resolution